Nuri Özkütük
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nuri Özkütük has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Serkan Oncu
Department of Infectious Diseases and Clinical Microbiology, Adnan Menderes University Faculty of Medicine, Aydin, Turkey
2 shared publications Süheyla Sürücüoğlu
2 shared publications- Süheyla Sürücüoğlu
Manisa Celal Bayar Univ, Tip Fak, Tibbi Mikrobiyol Anabilim Dali, Manisa, Turkiye
2 shared publications - Ahmet Yilmaz Coban
Akdeniz Universitesi
1 shared publication - Alper Şener
Department of Infectious Diseases, Katip Çelebi University Atatürk Training and Research Hospital, İzmir, Türkiye
1 shared publication - Arjan Harxhi
Infectious Disease Service, University Hospital Center of Tirana, 1001 Tirana, Albania
1 shared publication
Latest Publications
- Open Access
- 1 January 2017
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 83 (1) , 133-135
Chronic subcutaneous nodules, plaques and ulcers of the hand
- 1 January 2017
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 83 (1) , 133-135
Open AccessChronic subcutaneous nodules, plaques and ulcers of the hand
- Open Access
- 4 November 2015
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 14 (1) , 47
Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study
Tuberculous meningitis (TBM) caused by Mycobacterium tuberculosis resistant to antituberculosis drugs is an increasingly common clinical problem. This study aimed to evaluate drug resistance profiles of TBM isolates in adult patients in nine European countries involving 32 centers to provide insight into the empiric treatment of TBM. Mycobacterium tuberculosis was cultured from the cerebrospinal fluid (CSF) of 142 patients and was tested for susceptibility to first-line antituberculosis drugs, streptomycin (SM), isoniazid (INH), rifampicin (RIF) and ethambutol (EMB). Twenty of 142 isolates (14.1 %) were resistant to at least one antituberculosis drug, and five (3.5 %) were resistant to at least INH and RIF, [multidrug resistant (MDR)]. The resistance rate was 12, 4.9, 4.2 and 3.5 % for INH, SM, EMB and RIF, respectively. The monoresistance rate was 6.3, 1.4 and 0.7 % for INH, SM and EMB respectively. There was no monoresistance to RIF. The mortality rate was 23.8 % in fully susceptible cases while it was 33.3 % for those exhibiting monoresistance to INH, and 40 % in cases with MDR-TBM. In compared to patients without resistance to any first-line drug, the relative risk of death for INH-monoresistance and MDR-TBM was 1.60 (95 % CI, 0.38–6.82) and 2.14 (95 % CI, 0:34–13:42), respectively. INH-resistance and MDR rates seemed not to be worrisome in our study. However, considering their adverse effects on treatment, rapid detection of resistance to at least INH and RIF would be most beneficial for designing anti-TB therapy. Still, empiric TBM treatment should be started immediately without waiting the drug susceptibility testing.
- 4 November 2015
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 14 (1) , 47
Open AccessAntituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study
Tuberculous meningitis (TBM) caused by Mycobacterium tuberculosis resistant to antituberculosis drugs is an increasingly common clinical problem. This study aimed to evaluate drug resistance profiles of TBM isolates in adult patients in nine European countries involving 32 centers to provide insight into the empiric treatment of TBM. Mycobacterium tuberculosis was cultured from the cerebrospinal fluid (CSF) of 142 patients and was tested for susceptibility to first-line antituberculosis drugs, streptomycin (SM), isoniazid (INH), rifampicin (RIF) and ethambutol (EMB). Twenty of 142 isolates (14.1 %) were resistant to at least one antituberculosis drug, and five (3.5 %) were resistant to at least INH and RIF, [multidrug resistant (MDR)]. The resistance rate was 12, 4.9, 4.2 and 3.5 % for INH, SM, EMB and RIF, respectively. The monoresistance rate was 6.3, 1.4 and 0.7 % for INH, SM and EMB respectively. There was no monoresistance to RIF. The mortality rate was 23.8 % in fully susceptible cases while it was 33.3 % for those exhibiting monoresistance to INH, and 40 % in cases with MDR-TBM. In compared to patients without resistance to any first-line drug, the relative risk of death for INH-monoresistance and MDR-TBM was 1.60 (95 % CI, 0.38–6.82) and 2.14 (95 % CI, 0:34–13:42), respectively. INH-resistance and MDR rates seemed not to be worrisome in our study. However, considering their adverse effects on treatment, rapid detection of resistance to at least INH and RIF would be most beneficial for designing anti-TB therapy. Still, empiric TBM treatment should be started immediately without waiting the drug susceptibility testing.
- Open Access
- 16 September 2014
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 13 (1) , 44
Antimicrobial susceptibility and resistance mechanisms of methicillin resistant Staphylococcus aureusisolated from 12 Hospitals in Turkey
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most important nosocomial pathogens and is also emerging in Turkish hospitals. The aim of this study was to determine the antimicrobial susceptibility profiles of MRSA isolated from Turkish hospitals.
- 16 September 2014
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 13 (1) , 44
Open AccessAntimicrobial susceptibility and resistance mechanisms of methicillin resistant Staphylococcus aureusisolated from 12 Hospitals in Turkey
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most important nosocomial pathogens and is also emerging in Turkish hospitals. The aim of this study was to determine the antimicrobial susceptibility profiles of MRSA isolated from Turkish hospitals.
- 28 April 2014
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 48 (2) , 223-232
Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in an Intermediate-Prevalence Setting
<%=header_description %> <%=header_description %> Orta Prevalanslı Bölgede Akciğer ve Akciğer Dışı Tüberküloz Tanısında Xpert MTB/RIF Testinin Değerlendirilmesi Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in an Intermediate-Prevalence Setting
- 28 April 2014
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 48 (2) , 223-232
Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in an Intermediate-Prevalence Setting
<%=header_description %> <%=header_description %> Orta Prevalanslı Bölgede Akciğer ve Akciğer Dışı Tüberküloz Tanısında Xpert MTB/RIF Testinin Değerlendirilmesi Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in an Intermediate-Prevalence Setting
- Open Access
- 1 January 2010
- Published by Turkiye Klinikleri in Turkiye Klinikleri Journal of Medical Sciences
- Vol. 30 (5) , 1469-1475
Comparison of Löwenstein Jensen Medium and Bactec 460TB Culture System for Diagnosis of Tuberculosis
Amaç: Bu çalışmada tüberküloz tanısında BACTEC 460TB sıvı kültür sistemi ile birlikte Löwenstein Jensen besiyeri kullanımının, bakterinin izolasyon oranına katkı sağlayıp sağlamadığı araştırılmıştır. Gereç ve Yöntemler: Araştırmada toplam 4237 örneğin mikroskobik inceleme ve kültür sonuçları değerlendirilmiştir. Örneklerin 2719u solunum yolundan, 1518i ise solunum yolu dışından elde edilen hasta örnekleridir. Bulgular: Kültür sonuçlarına göre, 271 örnekte (%6.4) BACTEC 460TB sisteminde, 238 örnekte (%5.6) ise Löwenstein Jensen besiyerinde Mycobacterium tuberculosis kompleks üremiştir. Kontaminasyon oranları 12B şişelerinde %3.6, Löwenstein Jensen besiyerinde ise %10.2dir. Üreme süreleri ise BACTEC sisteminde ortalama 9.6 gün, Löwenstein Jensen besiyerinde ise 21 gün olarak belirlenmiştir. Kontamine olan örnekler çıkarıldığında, 3718 örneğin 258inde (%6.9) örnekte en az bir kültür yöntemi ile Mycobacterium tuberculosis kompleks ürediği gözlenmiştir. BACTEC 460TB kültür sisteminin duyarlılığı %96, Löwenstein Jensen besiyerinin duyarlılığı ise %92 olarak bulunmuştur. Her iki kültür yöntemi arasında %99 oranında uyum gözlenmiştir. Tek başına BACTEC 460TB sisteminin ve LJ besiyerinin kültür pozitifliğine katkısı sırası ile %8.3 ve %3.9 olarak bulunmuştur. Kültürde üreyen örneklerin mikroskobik inceleme sonuçları ile üredikleri kültür sistemleri karşılaştırıldığında istatistiksel olarak anlamlılık gözlenmemiştir. Sonuç: Tüberkülozun hızlı tanısında sıvı kültür sistemlerinin önemli bir gereksinim olduğu, ancak en yüksek izolasyon oranına ulaşabilmek için hem sıvı hem de katı kültür sistemlerinin birlikte kullanılmasının gerektiği düşünülmüştür.
- 1 January 2010
- Published by Turkiye Klinikleri in Turkiye Klinikleri Journal of Medical Sciences
- Vol. 30 (5) , 1469-1475
Open AccessComparison of Löwenstein Jensen Medium and Bactec 460TB Culture System for Diagnosis of Tuberculosis
Amaç: Bu çalışmada tüberküloz tanısında BACTEC 460TB sıvı kültür sistemi ile birlikte Löwenstein Jensen besiyeri kullanımının, bakterinin izolasyon oranına katkı sağlayıp sağlamadığı araştırılmıştır. Gereç ve Yöntemler: Araştırmada toplam 4237 örneğin mikroskobik inceleme ve kültür sonuçları değerlendirilmiştir. Örneklerin 2719u solunum yolundan, 1518i ise solunum yolu dışından elde edilen hasta örnekleridir. Bulgular: Kültür sonuçlarına göre, 271 örnekte (%6.4) BACTEC 460TB sisteminde, 238 örnekte (%5.6) ise Löwenstein Jensen besiyerinde Mycobacterium tuberculosis kompleks üremiştir. Kontaminasyon oranları 12B şişelerinde %3.6, Löwenstein Jensen besiyerinde ise %10.2dir. Üreme süreleri ise BACTEC sisteminde ortalama 9.6 gün, Löwenstein Jensen besiyerinde ise 21 gün olarak belirlenmiştir. Kontamine olan örnekler çıkarıldığında, 3718 örneğin 258inde (%6.9) örnekte en az bir kültür yöntemi ile Mycobacterium tuberculosis kompleks ürediği gözlenmiştir. BACTEC 460TB kültür sisteminin duyarlılığı %96, Löwenstein Jensen besiyerinin duyarlılığı ise %92 olarak bulunmuştur. Her iki kültür yöntemi arasında %99 oranında uyum gözlenmiştir. Tek başına BACTEC 460TB sisteminin ve LJ besiyerinin kültür pozitifliğine katkısı sırası ile %8.3 ve %3.9 olarak bulunmuştur. Kültürde üreyen örneklerin mikroskobik inceleme sonuçları ile üredikleri kültür sistemleri karşılaştırıldığında istatistiksel olarak anlamlılık gözlenmemiştir. Sonuç: Tüberkülozun hızlı tanısında sıvı kültür sistemlerinin önemli bir gereksinim olduğu, ancak en yüksek izolasyon oranına ulaşabilmek için hem sıvı hem de katı kültür sistemlerinin birlikte kullanılmasının gerektiği düşünülmüştür.
- 1 October 2008
- Vol. 42 (4) , 585-90
[Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].
Pyrazinamide (PZA) is a primary antituberculous drug. BACTEC 460TB is the recommended reference method for the detection of PZA resistance in Mycobacterium tuberculosis. This method is more expensive than the conventional susceptibility methods and therefore, it is recommended that each laboratory should establish their own protocol for the inclusion of PZA in the panel of primary drugs tested. One of the most important factors that help this decision is the prevalence of PZA resistance, particularly PZA monoresistance in the related community. The aim of the present study was to determine the extent of PZA monoresistance in M. tuberculosis complex (MTBC) isolates in our region. In this study, PZA susceptibility testing of 109 MTBC strains (susceptible to isoniazid, rifampicin, ethambutol and streptomycin) isolated from Manisa province in the Aegean region of Turkey was performed by using the BACTEC 460TB radiometric system (Becton Dickinson, MD). Two (1.8%) of the 109 isolates which were susceptible to all primary drugs revealed monoresistance against PZA. One of the PZA-monoresistant isolates has been identified as M. bovis and the other as M. tuberculosis by molecular method (Genotype MTBC, Hain Lifescience, Germany). The results of our study indicated that since the rate of PZA monoresistance was low, susceptibility testing of a panel of primary drugs without PZA may be an economical alternative in our region.
- 1 October 2008
- Vol. 42 (4) , 585-90
[Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].
Pyrazinamide (PZA) is a primary antituberculous drug. BACTEC 460TB is the recommended reference method for the detection of PZA resistance in Mycobacterium tuberculosis. This method is more expensive than the conventional susceptibility methods and therefore, it is recommended that each laboratory should establish their own protocol for the inclusion of PZA in the panel of primary drugs tested. One of the most important factors that help this decision is the prevalence of PZA resistance, particularly PZA monoresistance in the related community. The aim of the present study was to determine the extent of PZA monoresistance in M. tuberculosis complex (MTBC) isolates in our region. In this study, PZA susceptibility testing of 109 MTBC strains (susceptible to isoniazid, rifampicin, ethambutol and streptomycin) isolated from Manisa province in the Aegean region of Turkey was performed by using the BACTEC 460TB radiometric system (Becton Dickinson, MD). Two (1.8%) of the 109 isolates which were susceptible to all primary drugs revealed monoresistance against PZA. One of the PZA-monoresistant isolates has been identified as M. bovis and the other as M. tuberculosis by molecular method (Genotype MTBC, Hain Lifescience, Germany). The results of our study indicated that since the rate of PZA monoresistance was low, susceptibility testing of a panel of primary drugs without PZA may be an economical alternative in our region.
- 1 April 2007
- Vol. 41 (2) , 193-202
[Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
Tuberculin skin test which is used for the detection of latent tuberculosis (TB), has many disadvantages such as false positivities due to cross reactions between environmental mycobacteria and BCG strain, false negativities due to immunosuppression and malpractice, and also difficulties in application and evaluation. Recently a new diagnostic test which measures the production of interferon (IFN)-gamma in whole blood upon stimulation with specific ESAT-6 and CFP-10 antigens of Mycobacterium tuberculosis has been introduced. Since most of the mycobacteria other than tuberculosis and BCG strain do not contain these antigens, the detection of IFN-gamma levels indicates the specific T-cell response against M. tuberculosis. The aim of the study was to compare the tuberculin skin test and whole blood IFN-gamma assay (QuantiFERON-TB Gold, Cellestis Ltd, Carnegie, Victoria, Australia) for the identification of latent TB infection in the contacts with active TB patients. The tests results were evaluated by using Kappa (K) analysis, and K coefficients of < 0.4, 0.4-0.75 and > 0.75 were accepted as poor, moderate and excellent agreements, respectively. A total of 233 subjects from three risk groups were included to the study. Group 1 included the household members (n = 133) who had contact with smear positive index cases, Group 2 included the subjects from community (n = 46) who had contact with smear positive index cases, and Group 3 included health care workers (n = 74) who had contact with TB patients or their specimens. The positivity rates of tuberculin skin test and IFN-gamma assay in the cases were found as 37% and 42%, respectively. There were no significant differences among the three patient groups with regard to the results of the tuberculin skin test (p > 0.05). However, the positive result of the IFN-gamma assay in Group 1 was found statistically higher than the other groups (51.3%, p = 0.013). A poor agreement between the two tests was detected in the results taken from 233 subjects (65.7%, K = 0.28), while agreement was moderate in unvaccinated group (72.7%, K = 0.44). Evaluation of agreement rates of the tests according to the risk groups yielded 64.6% (K = 0.3) for Group 1, 71.7% (K = 0.32) for Group 2, and 63.5% (K = 0.21) for Group 3, which all coefficients showed poor agreement. Although IFN-gamma blood assay has many advantages such as objective and quantitative results, no interference with vaccination due to the use of specific antigens and being practical, the high cost and the need for well-equipped laboratory are its disadvantages. As a result it was concluded that, IFN-gamma blood assay has limited value for the detection of latent TB infection in our country, since the prevalence of TB infection and BCG vaccination rates are high in Turkey.
- 1 April 2007
- Vol. 41 (2) , 193-202
[Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
Tuberculin skin test which is used for the detection of latent tuberculosis (TB), has many disadvantages such as false positivities due to cross reactions between environmental mycobacteria and BCG strain, false negativities due to immunosuppression and malpractice, and also difficulties in application and evaluation. Recently a new diagnostic test which measures the production of interferon (IFN)-gamma in whole blood upon stimulation with specific ESAT-6 and CFP-10 antigens of Mycobacterium tuberculosis has been introduced. Since most of the mycobacteria other than tuberculosis and BCG strain do not contain these antigens, the detection of IFN-gamma levels indicates the specific T-cell response against M. tuberculosis. The aim of the study was to compare the tuberculin skin test and whole blood IFN-gamma assay (QuantiFERON-TB Gold, Cellestis Ltd, Carnegie, Victoria, Australia) for the identification of latent TB infection in the contacts with active TB patients. The tests results were evaluated by using Kappa (K) analysis, and K coefficients of < 0.4, 0.4-0.75 and > 0.75 were accepted as poor, moderate and excellent agreements, respectively. A total of 233 subjects from three risk groups were included to the study. Group 1 included the household members (n = 133) who had contact with smear positive index cases, Group 2 included the subjects from community (n = 46) who had contact with smear positive index cases, and Group 3 included health care workers (n = 74) who had contact with TB patients or their specimens. The positivity rates of tuberculin skin test and IFN-gamma assay in the cases were found as 37% and 42%, respectively. There were no significant differences among the three patient groups with regard to the results of the tuberculin skin test (p > 0.05). However, the positive result of the IFN-gamma assay in Group 1 was found statistically higher than the other groups (51.3%, p = 0.013). A poor agreement between the two tests was detected in the results taken from 233 subjects (65.7%, K = 0.28), while agreement was moderate in unvaccinated group (72.7%, K = 0.44). Evaluation of agreement rates of the tests according to the risk groups yielded 64.6% (K = 0.3) for Group 1, 71.7% (K = 0.32) for Group 2, and 63.5% (K = 0.21) for Group 3, which all coefficients showed poor agreement. Although IFN-gamma blood assay has many advantages such as objective and quantitative results, no interference with vaccination due to the use of specific antigens and being practical, the high cost and the need for well-equipped laboratory are its disadvantages. As a result it was concluded that, IFN-gamma blood assay has limited value for the detection of latent TB infection in our country, since the prevalence of TB infection and BCG vaccination rates are high in Turkey.